Skip to main content
PMC home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1979 Jan;65(1):147–154. doi: 10.1111/j.1476-5381.1979.tb17343.x

The metabolism of 5-hydroxytryptamine and beta-phenylethylamine in perfused rat lung and in vitro.

Y S Bakhle, M B Youdim
PMCID: PMC1668464  PMID: 32944

Abstract

1 Metabolism of 5-hydroxytryptamine (5-HT) and beta-phenylethylamine (PHE) by monoamine oxidase (MAO) was investigated in rat isolated lungs and in mitochondrial preparations from rat lung. 2. In perfused lungs 5-HT metabolism had an apparent Km of 2 microgram and PHE metaoblism a Km of 54 microgram, whereas in vitro the Km values were 330 microgram and 28 microgram respectively. 3 In vitro, MAO activity had substrate and inhibitor specificities compatible with the presence of A and B types of MAO. 4 In perfused lung, metabolism of 5-HT but not that of PHE was inhibited by desmethylimipramine. 5 These results show that PHE metabolism in perfused lung, unlike that of other metabolized amines, is not limited by transport and the transport process for PHE is unlike that of 5-HT or noradrenaline. 6 These results also show that the kinetic parameters obtained for MAO activity in vitro do not generally apply to the isolated lung where transport of substrate can be the deciding factor. This discrepancy emphasizes that the enzymic properties of the whole organ cannot relaibly be deduced from its enzymic content.

Full text

PDF
147

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alabaster V. A., Bakhle Y. S. Removal of 5-hydroxytryptamine in the pulmonary circulation of rat isolated lungs. Br J Pharmacol. 1970 Nov;40(3):468–482. [PMC free article] [PubMed] [Google Scholar]
  2. Alabaster V. A., Bakhle Y. S. The removal of noradrenaline in the pulmonary circulation of rat isolated lungs. Br J Pharmacol. 1973 Feb;47(2):325–331. doi: 10.1111/j.1476-5381.1973.tb08330.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bakhle Y. S., Vane J. R. Pharmacokinetic function of the pulmonary circulation. Physiol Rev. 1974 Oct;54(4):1007–1045. doi: 10.1152/physrev.1974.54.4.1007. [DOI] [PubMed] [Google Scholar]
  4. Bakhle Y. S., Youdim M. B. Metabolism of phenylethylamine in rat isolated perfused lung: evidence for monoamine oxidase 'type B' in lung. Br J Pharmacol. 1976 Jan;56(1):125–127. doi: 10.1111/j.1476-5381.1976.tb06967.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Boileau J. C., Crexells C., Biron P. Free pulmonary passage of dopamine. Rev Can Biol. 1972 Mar;31(1):69–72. [PubMed] [Google Scholar]
  6. Durden D. A., Philips S. R., Boulton A. A. Identification and distribution of beta-phenylethylamine in the rat. Can J Biochem. 1973 Jul;51(7):995–1002. doi: 10.1139/o73-129. [DOI] [PubMed] [Google Scholar]
  7. Gillis C. N., Roth J. A. Pulmonary disposition of circulating vasoactive hormones. Biochem Pharmacol. 1976 Dec 1;25(23):2547–2553. doi: 10.1016/0006-2952(76)90508-6. [DOI] [PubMed] [Google Scholar]
  8. Gillis C. N., Roth J. A. The fate of biogenic monoamines in perfused rabbit lung. Br J Pharmacol. 1977 Apr;59(4):585–590. doi: 10.1111/j.1476-5381.1977.tb07725.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Ginn R., Vane J. R. Disappearance of catecholamines from the circulation. Nature. 1968 Aug 17;219(5155):740–742. doi: 10.1038/219740a0. [DOI] [PubMed] [Google Scholar]
  10. Houslay M. D., Tipton K. F. A kinetic evaluation of monoamine oxidase activity in rat liver mitochondrial outer membranes. Biochem J. 1974 Jun;139(3):645–652. doi: 10.1042/bj1390645. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Houslay M. D., Tipton K. F. Multiple forms of monoamine oxidase: fact and artefact. Life Sci. 1976 Aug 15;19(4):467–477. doi: 10.1016/0024-3205(76)90224-1. [DOI] [PubMed] [Google Scholar]
  12. Hughes J., Gillis C. N., Bloom F. E. The uptake and disposition of dl-norepinephrine in perfused rat lung. J Pharmacol Exp Ther. 1969 Oct;169(2):237–248. [PubMed] [Google Scholar]
  13. Iwasawa Y., Gillis C. N., Aghajanian G. Hypothermic inhibition of 5-hydroxytryptamine and norepinephrine uptake by lung: cellular location of amines after uptake. J Pharmacol Exp Ther. 1973 Sep;186(3):498–507. [PubMed] [Google Scholar]
  14. Junod A. F. Accumulation of 14 C-imipramine in isolated perfused rat lungs. J Pharmacol Exp Ther. 1972 Oct;183(1):182–187. [PubMed] [Google Scholar]
  15. Junod A. F. Uptake, metabolism and efflux of 14 C-5-hydroxytryptamine in isolated perfused rat lungs. J Pharmacol Exp Ther. 1972 Nov;183(2):341–355. [PubMed] [Google Scholar]
  16. Krajl M. A rapid microfluorimetric determination of monoamine oxidase. Biochem Pharmacol. 1965 Nov;14(11):1684–1686. doi: 10.1016/0006-2952(65)90025-0. [DOI] [PubMed] [Google Scholar]
  17. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  18. Nicholas T. E., Strum J. M., Angelo L. S., Junod A. F. Site and mechanism of uptake of 3H--norepinephrine by isolated perfused rat lungs. Circ Res. 1974 Nov;35(5):670–680. doi: 10.1161/01.res.35.5.670. [DOI] [PubMed] [Google Scholar]
  19. Roth J. A., Gillis C. N. Deamination of beta-phenylethylamine by monoamine oxidase--inhibition by imipramine. Biochem Pharmacol. 1974 Sep 15;23(18):2537–2545. doi: 10.1016/0006-2952(74)90176-2. [DOI] [PubMed] [Google Scholar]
  20. Saavedra J. M., Axelrod J. Demonstration and distribution of phenylethanolamine in brain and other tissues. Proc Natl Acad Sci U S A. 1973 Mar;70(3):769–772. doi: 10.1073/pnas.70.3.769. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Sadavongvivad C. Pharmacological significance of biogenic amines in the lungs: 5-hydroxytryptamine. Br J Pharmacol. 1970 Feb;38(2):353–365. doi: 10.1111/j.1476-5381.1970.tb08523.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Southgate J., Collins G. G. The estimation of monoamine oxidase using 14C-labelled substrates. Biochem Pharmacol. 1969 Sep;18(9):2285–2287. doi: 10.1016/0006-2952(69)90341-4. [DOI] [PubMed] [Google Scholar]
  23. VANE J. R. A sensitive method for the assay of 5-hydroxytryptamine. Br J Pharmacol Chemother. 1957 Sep;12(3):344–349. doi: 10.1111/j.1476-5381.1957.tb00146.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Youdim M. B., Holzbauer M. Physiological and pathological changes in tissue monoamine oxidase activity. J Neural Transm. 1976;38(3-4):193–229. doi: 10.1007/BF01249439. [DOI] [PubMed] [Google Scholar]
  25. Youdim M. B., Holzbauer M., Woods H. F. Physicochemical properties, development, and regulation of central and peripheral monoamine oxidase activity. Adv Biochem Psychopharmacol. 1974;12(0):11–28. [PubMed] [Google Scholar]
  26. Youdim M. B., Woods H. F. The influence of tissue environment on the rates of metabolic processes and the properties of enzymes. Biochem Pharmacol. 1975 Feb 1;24(3):317–323. doi: 10.1016/0006-2952(75)90212-9. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES